Benzo[a]pyrene phenols are more potent inducers of CYP1A1, CYP1B1 and COX-2 than benzo[a]pyrene glucuronides in cell lines derived from the human aerodigestive tract.
暂无分享,去创建一个
N. Altorki | L. Kopelovich | Erik G. Cohen | K. Subbaramaiah | A. Dannenberg | Jia-Long Fang | P. Lazarus | J. Boyle | B. Du | Taghreed Almahmeed | J. Carew
[1] K. Subbaramaiah,et al. Cyclooxygenase 2: a molecular target for cancer prevention and treatment. , 2003, Trends in pharmacological sciences.
[2] M. Manns,et al. Polymorphisms of the Carcinogen Detoxifying UDP-Glucuronosyltransferase UGT1A7 in Proximal Digestive Tract Cancer , 2002, Zeitschrift fur Gastroenterologie.
[3] M. Manns,et al. Polymorphisms of the human UDP-glucuronosyltransferase (UGT) 1A7 gene in colorectal cancer , 2002, Gut.
[4] T. Brüning,et al. Cytochrome P450 1B1, a new keystone in gene–environment interactions related to human head and neck cancer? , 2002, Archives of Toxicology.
[5] Philip Lazarus,et al. Glucuronidation: an important mechanism for detoxification of benzo[a]pyrene metabolites in aerodigestive tract tissues. , 2002, Drug metabolism and disposition: the biological fate of chemicals.
[6] C. Guillemette,et al. Characterization of benzo(a)pyrene-trans-7,8-dihydrodiol glucuronidation by human tissue microsomes and overexpressed UDP-glucuronosyltransferase enzymes. , 2002, Cancer research.
[7] L. Kaminsky,et al. Induction of CYP1A1 and CYP1B1 in T-47D human breast cancer cells by benzo[a]pyrene is diminished by arsenite. , 2002, Drug metabolism and disposition: the biological fate of chemicals.
[8] J. V. Vanden Heuvel,et al. The Q-rich Subdomain of the Human AhReceptor Transactivation Domain Is Required for Dioxin-mediated Transcriptional Activity* , 2001, The Journal of Biological Chemistry.
[9] M. Manns,et al. Genetic link of hepatocellular carcinoma with polymorphisms of the UDP-glucuronosyltransferase UGT1A7 gene. , 2001, Gastroenterology.
[10] C. Guillemette,et al. Tobacco carcinogen-detoxifying enzyme UGT1A7 and its association with orolaryngeal cancer risk. , 2001, Journal of the National Cancer Institute.
[11] N. Altorki,et al. Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer. , 2001, The Lancet. Oncology.
[12] Li Zhu,et al. Non-small Cell Lung Cancer Cyclooxygenase-2-dependent Invasion Is Mediated by CD44* , 2001, The Journal of Biological Chemistry.
[13] T. Brüning,et al. Association of CYP1B1 codon 432 mutant allele in head and neck squamous cell cancer is reflected by somatic mutations of p53 in tumor tissue. , 2001, Cancer research.
[14] M. Kay Washington,et al. Prostaglandin E2 Increases Growth and Motility of Colorectal Carcinoma Cells* , 2001, The Journal of Biological Chemistry.
[15] A. Pfeifer,et al. Cytochrome P450 expression and related metabolism in human buccal mucosa. , 2001, Carcinogenesis.
[16] C. Guillemette,et al. Structural heterogeneity at the UDP-glucuronosyltransferase 1 locus: functional consequences of three novel missense mutations in the human UGT1A7 gene. , 2000, Pharmacogenetics.
[17] J. Shah,et al. Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck. , 1999, Cancer research.
[18] M. Manns,et al. Regulation and function of family 1 and family 2 UDP-glucuronosyltransferase genes (UGT1A, UGT2B) in human oesophagus. , 1999, The Biochemical journal.
[19] T. Shimada,et al. Twenty years of biochemistry of human P450s: purification, expression, mechanism, and relevance to drugs. , 1998, Drug metabolism and disposition: the biological fate of chemicals.
[20] R. DuBois,et al. Cyclooxygenase Regulates Angiogenesis Induced by Colon Cancer Cells , 1998, Cell.
[21] P. Mackenzie,et al. Characterization of two UDP glucuronosyltransferases that are predominantly expressed in human colon. , 1998, Biochemical and biophysical research communications.
[22] T. Shimada,et al. Activation of procarcinogens by human cytochrome P450 enzymes. , 1998, Mutation research.
[23] J. Morrow,et al. Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells. , 1998, Cancer research.
[24] R. DuBois,et al. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[25] K. Subbaramaiah,et al. Benzo[a]pyrene up-regulates cyclooxygenase-2 gene expression in oral epithelial cells. , 1997, Carcinogenesis.
[26] K. Subbaramaiah,et al. Retinoids suppress phorbol ester-mediated induction of cyclooxygenase-2. , 1997, Cancer research.
[27] H. Yamazaki,et al. Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1. , 1996, Cancer research.
[28] P. Sacks. Cell, tissue and organ culture as in vitro models to study the biology of squamous cell carcinomas of the head and neck , 1996, Cancer and Metastasis Reviews.
[29] R. DuBois,et al. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2 , 1995, Cell.
[30] L. Crofford,et al. Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin‐1: a potential mechanism for inflammatory angiogenesis , 1995, FEBS letters.
[31] F. Guengerich,et al. Metabolic activation and carcinogen-DNA adduct detection in human larynx. , 1994, Cancer research.
[32] J. Miners,et al. The glucuronidation of hydroxylated metabolites of benzo[a]pyrene and 2-acetylaminofluorene by cDNA-expressed human UDP-glucuronosyltransferases. , 1993, Carcinogenesis.
[33] P. G. Wells,et al. In vitro and in vivo biotransformation and covalent binding of benzo(a)pyrene in Gunn and RHA rats with a genetic deficiency in bilirubin uridine diphosphate-glucuronosyltransferase. , 1992, The Journal of pharmacology and experimental therapeutics.
[34] J. Minna,et al. Mutations of ras genes distinguish a subset of non-small-cell lung cancer cell lines from small-cell lung cancer cell lines. , 1991, Oncogene.
[35] S. Pathak,et al. Establishment and characterization of two new squamous cell carcinoma cell lines derived from tumors of the head and neck. , 1988, Cancer research.
[36] K. Bock,et al. Release of mutagenic metabolites of benzo[a]pyrene from the perfused rat liver after inhibition of glucuronidation and sulfation by salicylamide. , 1981, Chemico-biological interactions.
[37] H. Towbin,et al. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. , 1979, Proceedings of the National Academy of Sciences of the United States of America.
[38] Nemoto Nobuo,et al. Modification of the mutagenicity of benzo(a)pyrene on bacteria by substrates of enzymes producing water soluble conjugates , 1978 .
[39] S. Orrenius,et al. Metabolism of benzo(a)pyrene with isolated hepatocytes and the formation and degradation of DNA-binding derivatives. , 1977, The Journal of biological chemistry.
[40] U. K. Laemmli,et al. Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.
[41] Oliver H. Lowry,et al. Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.
[42] P. Thompson,et al. Carcinogen substrate specificity of human COX-1 and COX-2. , 2001, Carcinogenesis.
[43] W. F. Greenlee,et al. Regulation, function, and tissue-specific expression of cytochrome P450 CYP1B1. , 2001, Annual review of pharmacology and toxicology.
[44] T. Eling,et al. Xenobiotic metabolism by prostaglandin H synthase. , 1992, Pharmacology & therapeutics.